BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34488797)

  • 1. Coevolution of COVID-19 research and China's policies.
    Cheng X; Tang L; Zhou M; Wang G
    Health Res Policy Syst; 2021 Sep; 19(1):121. PubMed ID: 34488797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. China's Public Health Policies in Response to COVID-19: From an "Authoritarian" Perspective.
    Gao J; Zhang P
    Front Public Health; 2021; 9():756677. PubMed ID: 34976920
    [No Abstract]   [Full Text] [Related]  

  • 3. Study on the Experience of Public Health System Construction in China's COVID-19 Prevention.
    Zhang P
    Front Public Health; 2021; 9():610824. PubMed ID: 33981659
    [No Abstract]   [Full Text] [Related]  

  • 4. Public Health Crises In Comparison: China's Epidemic Response Policies From SARS To COVID-19.
    Li M
    Glob Public Health; 2021; 16(8-9):1223-1236. PubMed ID: 33891518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status and Challenges of Public Health Emergency Management in China Related to COVID-19.
    Cao Y; Shan J; Gong Z; Kuang J; Gao Y
    Front Public Health; 2020; 8():250. PubMed ID: 32574311
    [No Abstract]   [Full Text] [Related]  

  • 6. [Suggestions on design of evidence-based traditional Chinese medicine clinical study for new public health emergencies].
    Wang LX; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2291-2295. PubMed ID: 32495582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Policy disparities in response to the first wave of COVID-19 between China and Germany.
    Zhang Y; Shi L; Chen H; Wang X; Sun G
    Int J Equity Health; 2021 Mar; 20(1):86. PubMed ID: 33766049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.
    Liu J; Zhou Y; Ye C; Zhang G; Zhang F; Song C
    Arch Public Health; 2021 Jan; 79(1):8. PubMed ID: 33441168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of COVID-19 Management Policies Tailored to Airborne SARS-CoV-2 Transmission: Policy Analysis.
    Telles CR; Roy A; Ajmal MR; Mustafa SK; Ahmad MA; de la Serna JM; Frigo EP; Rosales MH
    JMIR Public Health Surveill; 2021 Apr; 7(4):e20699. PubMed ID: 33729168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the patterns of China's policies against COVID-19: A bibliometric study.
    Wu J; Wang K; He C; Huang X; Dong K
    Inf Process Manag; 2021 Jul; 58(4):102562. PubMed ID: 33678941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
    Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
    Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public Engagement and Government Responsiveness in the Communications About COVID-19 During the Early Epidemic Stage in China: Infodemiology Study on Social Media Data.
    Liao Q; Yuan J; Dong M; Yang L; Fielding R; Lam WWT
    J Med Internet Res; 2020 May; 22(5):e18796. PubMed ID: 32412414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Study on International Research Hotspots and National-Level Policy Keywords of Dynamic Disaster Monitoring and Early Warning in China (2000-2021).
    Gao J; Zhang W; Yang C; Wang R; Shao S; Li J; Zhang L; Li Z; Liu S; Si W
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Pandemic and Comparative Health Policy Learning in Iran.
    Raoofi A; Takian A; Akbari Sari A; Olyaeemanesh A; Haghighi H; Aarabi M
    Arch Iran Med; 2020 Apr; 23(4):220-234. PubMed ID: 32271594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic evolution of policy mix in response to COVID-19: Practice from China.
    Du L; Lu W
    PLoS One; 2023; 18(9):e0291633. PubMed ID: 37768975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. China's "dynamic clearing" epidemic prevention policy: Achievements, challenges, and prospects.
    Wang Q; Huang L
    Front Public Health; 2022; 10():978944. PubMed ID: 36187631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical Insurance Information Systems in China: Mixed Methods Study.
    Li Y; Lu C; Liu Y
    JMIR Med Inform; 2020 Sep; 8(9):e18780. PubMed ID: 32673209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of China's Prevention and Control Strategy for the COVID-19 Epidemic.
    Wang J; Wang Z
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32225019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.
    Huang M; Wang J; Nicholas S; Maitland E; Guo Z
    J Med Internet Res; 2021 Jun; 23(6):e27345. PubMed ID: 34061761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflection and Foresight on Personal Information Protection and Optimization in Public Health Emergencies in China-From the Perspective of Personal Information Collection during the Period of China's Dynamic-Zero COVID-19 Prevention and Control Policy.
    Wang H
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.